Eric Wyffels

Showing 1-3 of 3 articles

Coronary interventions

Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents: the PROACTIVE trial

Pellicano M, Di Gioia G, Ciccarelli G, Xaplanteris P, Delrue L, Toth G, Van Durme F, Heyse A, Wyffels E, Vanderheyden M, Bartunek J, De Bruyne B, Barbato E

June 12, 2020 | 10.4244/EIJ-D-18-01138

Co-registration of fractional flow reserve and optical coherence tomography with the use of a three-dimensional angiographic roadmap: an opportunity for optimisation of complex percutaneous coronary interventions

Pyxaras S, Tu S, Barbato E, Wyffels E, Reiber J, Wijns W

November 29, 2013 | 10.4244/EIJV9I7A146

Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis

Melikian N, Vercauteren S, Fearon W, Cuisset T, MacCarthy P, Davidavicius G, Aarnoudse W, Bartunek J, Vanderheyden M, Wyffels E, Wijns W, Heyndrickx G, Pijls N, De Bruyne B

April 12, 2010

1

Latest news

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

My Stroke Story

October 20, 2021

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

Valvular disease